Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.
Trial Details
- NCT ID
- NCT04172753
- Phase
- NA
- Sponsor
- University Hospital Tuebingen
- Status
- RECRUITING
- Cancer Type
- Breast Cancer
- Interventions
- Radiotherapy on the MR-Linac
- Imaging on the MR Linac
- Locations (sample)
- Tübingen, Baden-Wurttemberg, Germany|48.52266,9.05222
Key Eligibility Criteria
- existing indication for radiation therapy
- minimum age 18 years, no upper age limit
- capacity for consent
- Informed consent
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Breast Cancer Trials on Trialify →